De novo natural anti-M alloantibody emergence in severe Coronavirus Disease 2019
Robin Jeannet(Hôpital Universitaire Dupuytren), Xavier Lafarge(Inserm), Virginie Pascal(Centre National de la Recherche Scientifique), Thomas Daix, Sébastien Hantz(Université de Limoges), Sophie Le Cam(Centre Pays de la Loire), Hélène Pauthier(Hôpital Pellegrin), Alexandra Descazeaud(Hôpital Pellegrin), Bruno François(Inserm), Jean Feuillard(Centre National de la Recherche Scientifique)
Cited by 5
Related Papers
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
|Critical Care|2019|976
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890